CAT and metabolic syndrome: Additionally, JPP treatment recovered T2DM dyslipidemia in a dose-dependent manner and restored nonenzymatic antioxidant defences (NPSH and GSH/GSSG ratio), without changes in the enzymatic antioxidant defences (SOD, CAT, TrxR-1, GPx, and GST activities).